A blood test to screen for colorectal cancer is one step closer to receiving approval from the U.S. Food and Drug Administration. An FDA advisory panel -- the Medical Devices Advisory Committee ...
May 23 (UPI) --A panel of U.S. Food and Drug Administration advisers on Thursday recommended approval for a new blood test to detect colon and rectal cancer despite concerns over the test's accuracy.
The Shield blood test was able to accurately detect colorectal cancer about 83 percent of the time. It was able to detect precancerous lesions about 13 percent of the time. The prescription-only ...
To screen for colon and rectal cancers, most people have colonoscopies, which can feel invasive and require anesthesia, or they may take an at-home stool test, which can be more convenient but ...
Multi-cancer early detection tests (MCEDs), sometimes called liquid biopsy tests, are a new method of detecting cancer early.
On May 16, 2024, the FDA granted a breakthrough therapy designation to NVL-655, a novel brain-penetrant ALK-selective ...
There's potential good news for a sizable minority of people battling advanced colon cancer. Doctors in Britain say that an ...
Results from a new trial indicate that immunotherapy could successfully be used to treat the most common form of colorectal ...
Though no one wants a tumor, having a doctor tell you they've detected one is not the same as being told you have cancer.